Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues. Table of Contents <ul>
<li>Front Matter</li>
<li>Summary</li>
<li>Introduction</li>
<li>Workshop Summary</li>
<li>Appendix A</li>
<li>Appendix B</li>
<li>Appendix C</li>
</ul>

Orphans and Incentives: Developing Technology to Address Emerging Infections

Health, Fitness & Dieting

Forum on Emerging Infections

INSTITUTE OF MEDICINE

Diseases & Physical Ailments

National Academies Press

Antibiotic resistance is neither a surprising nor a new phenomenon. It is an increasingly worrisome situation, however, because resistance is growing and accelerating while the world's tools for combating it decrease in power and number. In addition, the cost of the problem--especially of multidrug resistance--in terms of money, mortality, and disability are also rising. This book summarizes a workshop on antimicrobial resistance held by the Forum on Emerging Infections. The goal of the Forum on Emerging Infections is to provide an opportunity for representatives of academia, industry, government, and professional and interest groups to examine and discuss scientific and policy dilemmas of common interest that are specifically related to research on and the prevention, detection, and management of emerging infections. Organized as a topic-by-topic synthesis of presentations and exchanges during the workshop, the book highlights lessons learned, delineates a range of pivotal issues and the problems they raise, and proposes some simplified ideas about possible responses. Table of Contents <ul>
<li>Front Matter</li>
<li>Workshop Summary</li>
<li>Workshop Report</li>
<li>Appendix A: Inventory of Surveillance Systems</li>
<li>Appendix B: American Society for Microbiology Recommendations</li>
<li>Appendix C: Glossary and Acronyms</li>
<li>Appendix D: Workshop Agenda</li>
</ul>

Antimicrobial Resistance: Issues and Options

Science & Math

Biological Sciences

The Forum on Emerging Infections was created in 1996 in response to a request from the Centers for Disease Control and Prevention and the National Institutes of Health. The goal of the forum is to provide structured opportunities for representatives from academia, industry, professional and interest groups, and government to examine and discuss scientific and policy issues that relate to research, prevention, detection, and management of emerging infectious diseases. A critical part of this mission has been the convening of a series of workshops. Public Health Systems and Emerging Infections summarizes the fourth in a series of five workshops.  With a focus on our knowledge and understanding of the role of private and public health sectors in emerging infectious disease surveillance and response, the participants explored the effects of privatization of public health laboratories and the modernization of public health care. The issues discussed included epidemiological investigation, surveillance, communication, coordination, resource allocations, and economic support. Table of ContentsFront MatterSummary and Assessment1 Introduction2 Epidemiological Investigation3 Surveillance4 Communication, Coordination, and Education and Outreach5 Strategic Planning, Resource Allocation, and Economic SupportReferencesAppendix A Glossary and AcronymsAppendix B Workshop AgendaAppendix C Emerging Infectious Diseases: Consensus on Needed Laboratory Capacity Could Strengthen SurveillanceAppendix D Forum Member and Staff Biographies

Public Health Systems and Emerging Infections: Assessing the Capabilities of the Public and Private Sectors: Workshop Summary

Division of Health Sciences Policy

In October 1999, the Forum on Emerging Infections of the Institute of Medicine convened a two-day workshop titled â€œInternational Aspects of Emerging Infections.â€ Key representatives from the international community explored the forces that drive emerging infectious diseases to prominence. Representatives from the Americas, Africa, Asia and the Pacific, and Europe made formal presentations and engaged in panel discussions. Emerging Infectious Diseases from the Global to the Local Perspective includes summaries of the formal presentations and suggests an agenda for future action. The topics addressed cover a wide range of issues, including trends in the incidence of infectious diseases around the world, descriptions of the wide variety of factors that contribute to the emergence and reemergence of these diseases, efforts to coordinate surveillance activities and responses within and across borders, and the resource, research, and international needs that remain to be addressed. Table of ContentsFront MatterSummary and AssessmentIntroductionEmerging Infections in Latin AmericaEmerging Infections in AfricaEmerging Infections in Asia and the PacificEmerging Infections in EuropeReferencesAppendix A: Glossary and AcronymsAppendix B: Workshop AgendaAppendix C: Workshop ParticipantsAppendix D: Forum Member and Staff Biographies

Emerging Infectious Diseases from the Global to the Local Perspective: A Summary of a Workshop of the Forum on Emerging Infections

Reference

Board on Global Health

Encyclopedias & Subject Guides

In the wake of September 11th and recent anthrax events, our nationâ€™s bioterrorism response capability has become an imminent priority for policymakers, researchers, public health officials, academia, and the private sector. In a three-day workshop, convened by the Institute of Medicineâ€™s Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities. From the discussions, it became clear that of utmost urgency is the need to cast the issue of a response in an appropriate framework in order to attract the attention of Congress and the public in order to garner sufficient and sustainable support for such initiatives. No matter how the issue is cast, numerous workshop participants agreed that there are many gaps in the public health infrastructure and countermeasure capabilities that must be prioritized and addressed in order to assure a rapid and effective response to another bioterrorist attack. Table of Contents <ul>
<li>Front Matter</li>
<li>Summary and Assessment</li>
<li>1 Introduction</li>
<li>2 Assessing Our Understanding of the Threats</li>
<li>3 Vaccines: Research, Development, Production, and Procurement Issues</li>
<li>4 The Research Agenda: Implications for Therapeutic Countermeasures to Biological Threats</li>
<li>5 Assessing the Capacity of the Public Health Infrastructure</li>
<li>6 Scientific and Policy Tools for Countering Bioterrorism</li>
<li>Appendix A: Agenda: Biological Threats and Terrorism: How Preparted Are We?</li>
<li>Appendix B: Information Resources</li>
<li>Appendix C: Testimony of Joshua Lederberg, Ph.D.</li>
<li>Appendix D: Summary of the Frist-Kennedy</li>
<li>Appendix E: Department of Health and Human Services: Food and Drug Administration</li>
<li>Appendix F: Veterans Affairs/Department of Defense Contingency</li>
<li>Appendix G: The Model State Emergency Health Powers Act</li>
<li>Appendix H: NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness</li>
<li>Appendix I: Statement on Vaccine Development</li>
<li>Appendix J: Testimony of Kenneth Shine, M.D.</li>
<li>Appendix K: Glossary and Acronyms</li>
<li>Appendix L: Forum Member, Speaker, and Staff Biographies</li>
</ul>

Biological Threats and Terrorism: Assessing the Science and Response Capabilities, Workshop Summary

History

Military

Zoonotic diseases represent one of the leading causes of illness and death from infectious disease. Defined by the World Health Organization, zoonoses are â€œthose diseases and infections that are naturally transmitted between vertebrate animals and man with or without an arthropod intermediate.â€ Worldwide, zoonotic diseases have a negative impact on commerce, travel, and economies. In most developing countries, zoonotic diseases are among those diseases that contribute significantly to an already overly burdened public health system. In industrialized nations, zoonotic diseases are of particular concern for at-risk groups such as the elderly, children, childbearing women, and immunocompromised individuals. The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health, covers a range of topics, which include: an evaluation of the relative importance of zoonotic diseases against the overall backdrop of emerging infections; research findings related to the current state of our understanding of zoonotic diseases; surveillance and response strategies to detect, prevent, and mitigate the impact of zoonotic diseases on human health; and information about ongoing programs and actions being taken to identify the most important needs in this vital area. Table of Contents <ul>
<li>Front Matter</li>
<li>1 Introduction</li>
<li>2 The Importance of Zoonotic Diseases</li>
<li>3 Factors of Emergence</li>
<li>4 Diagnosis and Control of Zoonotic Infections</li>
<li>5 Surveillance and Management of Zoonotic Disease Outbreaks</li>
<li>6 Summary and Assessment</li>
<li>Appendix A: Glossary and Acronyms</li>
<li>Appendix B: Workshop Agenda</li>
<li>Appendix C: Forum Member and Speaker Biographies</li>
</ul>

The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health: Workshop Summary

Engineering & Transportation

Engineering

Since smallpox eradication, the science of eradication has changed and with it, our definitions of what diseases are possible to eradicate. However, eradication must not beget complacency. As has been learned from past control or eradication attempts with a variety of viral diseases, from yellow fever to influenza, accidental or intentional reintroduction is a real threat -- one that could strike anywhere and for which we need to be fully prepared. The criteria for assessing eradicability of polio, measles, and other viral infections have been debated extensively. With the elimination and eradication of several viral diseases on the horizon, issues surrounding the cessation of immunization activities become exceedingly important. In an effort to better understand the dynamics of disease eradication and post--immunization policies, the Institute of Medicine Forum on Emerging Infections hosted a two-day workshop (February 1--2, 2001) on The Consequences of Viral Disease Eradication. This book explores the principles underlying the biological challenges, medical interventions, the continuing research agenda, and operational considerations for post--immunization strategies for vaccine--preventable viral diseases, and highlights important efforts that may facilitate wise decision making. Table of Contents <ul>
<li>Front Matter</li>
<li>Summary and Assessment</li>
<li>1 Introduction</li>
<li>2 Major Efforts for Disease Eradication</li>
<li>3 Biological Challenges to Post-Eradication</li>
<li>4 Operational and Instutional Challenges to Post-Eradication</li>
<li>5 Medical Intervention and Technological Solutions</li>
<li>6 The Challenges to Post-Eradication Outbreaks</li>
<li>Appendix A: Glossary and Acronyms</li>
<li>Appendix B: Workshop Agenda</li>
<li>Appendix C: Forum Member and Speaker Biographies</li>
</ul>

Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies: Workshop Summary

Medical Books

Basic Sciences

See the best price to sell, buy, or rent books by Forum on Emerging Infections. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Forum on Emerging Infections